Advertisement
U.S. markets open in 2 hours 55 minutes
  • S&P Futures

    5,306.00
    -2.25 (-0.04%)
     
  • Dow Futures

    40,137.00
    -7.00 (-0.02%)
     
  • Nasdaq Futures

    18,495.25
    -8.50 (-0.05%)
     
  • Russell 2000 Futures

    2,137.20
    -1.20 (-0.06%)
     
  • Crude Oil

    81.94
    +0.59 (+0.73%)
     
  • Gold

    2,226.50
    +13.80 (+0.62%)
     
  • Silver

    24.72
    -0.03 (-0.13%)
     
  • EUR/USD

    1.0793
    -0.0036 (-0.33%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • Vix

    12.97
    +0.19 (+1.49%)
     
  • GBP/USD

    1.2618
    -0.0020 (-0.16%)
     
  • USD/JPY

    151.4050
    +0.1590 (+0.11%)
     
  • Bitcoin USD

    70,392.25
    +254.16 (+0.36%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,959.26
    +27.28 (+0.34%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Nephros First Quarter 2022 Financial Results Conference Call

Nephros, Inc.
Nephros, Inc.

SOUTH ORANGE, NJ, April 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its first-quarter financial results on Wednesday, May 4, 2022 after market close and will host a conference call that same day at 4:30 PM ET.

Participants may dial into the call as follows:
Domestic access: 1 (844) 808-7106
International access: 1 (412) 317-5285

Upon joining, please ask to be joined into the Nephros conference call.

A replay of the call can be accessed until May 11th, 2022 at 1 (877) 344-7529 or 1 (412) 317-0088 for international callers and entering replay access code: 3792199.

An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page.

About Nephros

Nephros, Inc. is a company committed to improving the human relationship with water through leading, accessible technology. We provide innovative filtration and pathogen detection as part of an integrated approach to water safety that combines science, solutions, and support services. Nephros products serve the needs of customers within the healthcare and commercial markets, offering both proactive and emergency responses for water management. For more information about Nephros, please visit us at nephros.com.

Investor RelationsContacts:

Kirin Smith, President
PCG Advisory, Inc.
(646) 823-8656
ksmith@pcgadvisory.com

Andy Astor, CEO
Nephros, Inc.
(201) 345-0824
andy@nephros.com


Advertisement